Mr Anil Mankers Holdings as stated in 3 years of Annual Reports
Annual Report 2022
8. Equity instruments disclosures p23
Balance 1 January 2022.........100,589,833......Acquired /Disposed........(15,590,000)........Shares issued as remuneration......0.........shares issued on conversion of Restricted Stock Units or Performance Rights......0...............Balance 31 December 2022......84,999,833
Additional Shareholder Information as at 31 January 2023
Top 20 Shareholders p72
MERRILL LYNCH (AUSTRALIA) NOMINEES PTY LIMITED............85,972,440..........4.893 %
(1) 84,999,933 fully paid ordinary shares are held by Merrill Lynch (Australia) Nominees Pty Limited on behalf of MrMankar.
Annual Report 2023
8. Equity Instruments Disclosure p23
Balance held at 31 December 2023 ............84,999,833.......Acquired /Disposed.....0......Shares issued as remuneration......0......shares issued on conversion of Restricted Stock Units or Performance Rights............0
(1) 84,999,833 fully paid ordinary shares are held by Merrill Lynch (Australia) Nominees Pty Ltd on behalf of Mr Mankar.
Additional Shareholder Information as at 31 January 2024
Top 20 Shareholders p69
MERRILL LYNCH (AUSTRALIA) NOMINEES PTY LIMITED (1)..........86,833,100.........4.809%
(1) 84,999,933 fully paid ordinary shares are held by Merrill Lynch (Australia) Nominees Pty Limited on behalf of Mr Mankar.
Annual Report 2024
7. Equity instruments disclosures p35
Shareholdings of Key Management Personnel (including nominees)
Balance 1 January 2024.........84,999,833......Acquired /Disposed........(9,999,833)........Shares issued as remuneration......0.........Net change other(3)........(75,000,000)......Balance 31 December......0
(1) Mr Mankar’s fully paid ordinary shares are held by Merrill Lynch (Australia) Nominees Pty Ltd on behalf of Mr Mankar, who ceased to be a KMP upon his retirement at 31 December 2024
(3) Other than the adjustment for Mr Mankar upon ceasing to be a KMP, this column comprises shares issued on conversion of Restricted Stock Units or Performance Rights.
Additional shareholder information
As at 11 February 2025
Top 20 Shareholders p82
MERRILL LYNCH (AUSTRALIA) NOMINEES PTY LIMITED.......73,646,613......3.734
As Mr Mankar is no longer Key Management Personnel nor a substantial holder (31/12/2024) he is not required to report any change in holdings
- Forums
- ASX - By Stock
- BRN
- Ann: BrainChip Evaluates Redomiciling to US
BRN
brainchip holdings ltd
Add to My Watchlist
0.00%
!
20.0¢

Ann: BrainChip Evaluates Redomiciling to US, page-405
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $405.0M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $1.544M | 7.615M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61852 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 217258 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32537 | 0.200 |
25 | 968327 | 0.195 |
38 | 1574473 | 0.190 |
40 | 1943108 | 0.185 |
65 | 1281316 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 179258 | 6 |
0.210 | 1653584 | 26 |
0.215 | 846002 | 16 |
0.220 | 1267378 | 34 |
0.225 | 840448 | 18 |
Last trade - 16.20pm 27/06/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online